Reported Q: Q1 2025 Rev YoY: -36.4% EPS YoY: -85.8% Move: +14.74%
Aehr Test Systems
AEHR
$26.39 14.74%
Exchange NASDAQ Sector Technology Industry Semiconductors
Q1 2025
Published: Oct 11, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for AEHR

Reported

Report Date

Oct 11, 2024

Quarter Q1 2025

Revenue

13.12M

YoY: -36.4%

EPS

0.02

YoY: -85.8%

Market Move

+14.74%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $13.12M down 36.4% year-over-year
  • EPS of $0.02 decreased by 85.8% from previous year
  • Gross margin of 54.0%
  • Net income of 660.00K
  • ""We finished the first quarter with revenue and non-GAAP net income ahead of consensus estimates and are off to a good start to our fiscal year." - Gayn Erickson, CEO" - Gayn Erickson
AEHR
Aehr Test Systems

Executive Summary

Aehr Test Systems reported a challenging yet strategic first quarter of fiscal 2025, with revenue at $13.1 million, down 36% year-over-year. This decline reflects ongoing adjustments in the semiconductor market but is balanced by promising emerging opportunities in silicon carbide and AI semiconductor testing. Management confirmed their commitment to expanding their portfolio following the recent acquisition of Incal Technology, which enhances their capabilities in high-power applications, notably in AI and GPUs. With strong demand for WaferPak products and broadening applications across multiple markets, Aehr remains positioned for long-term growth despite current headwinds.

Key Performance Indicators

Revenue
Decreasing
13.12M
QoQ: -20.97% | YoY: -36.39%
Gross Profit
Decreasing
7.08M
53.95% margin
QoQ: -16.22% | YoY: -29.09%
Operating Income
Decreasing
159.00K
QoQ: -93.74% | YoY: -96.14%
Net Income
Decreasing
660.00K
QoQ: -97.23% | YoY: -85.88%
EPS
Decreasing
0.02
QoQ: -97.23% | YoY: -85.81%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 9.88 -0.11 -26.5% View
Q1 2026 10.97 -0.07 -16.4% View
Q4 2025 14.09 -0.10 -15.1% View
Q3 2025 18.31 -0.02 +142.1% View
Q2 2025 13.45 -0.03 -37.2% View
Q1 2025 13.12 0.02 -36.4% View